Issued by: Centers for Medicare & Medicaid Services (CMS)

Issue Date: January 30, 2020

Effective 10/11/2023, facilities are no longer required to be approved by CMS to perform carotid artery stenting (CAS) procedures under the Percutaneous Transluminal Angioplasty (PTA) Concurrent with Stenting of the Carotid Artery National Coverage Determination (NCD 20.7). 

Additionally, CMS will no longer update the list of approved CAS facilities on the CMS website and will remove the website at a future date.

Note: Under the updated NCD, facilities must meet the institutional and physician standards specified in the final decision memorandum for coverage.

 

HHS is committed to making its websites and documents accessible to the widest possible audience, including individuals with disabilities. We are in the process of retroactively making some documents accessible. If you need assistance accessing an accessible version of this document, please reach out to the guidance@hhs.gov.

DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.